Bosnia and Herzegovina
Tuberculosis profile
Population  2012 3.8 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.2 (0.18–0.22) 5.2 (4.6–5.8)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 2.8 (1.3–4.8) 73 (35–126)
Incidence  (includes HIV+TB) 1.9 (1.6–2.1) 49 (42–56)
Incidence (HIV+TB only)        
Case detection, all forms (%) 76 (66–88)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 569 (44) Relapse 108 (91)
Smear-negative 523 (40) Treatment after failure 0 (0)
Smear-unknown / not done 31 (2) Treatment after default 0 (0)
Extrapulmonary 176 (14) Other 11 (9)
Other 2 (<1)      
Total new 1 301   Total retreatment 119  
           
Other (history unknown) 0        
Total new and relapse 1 409   Total cases notified 1 420  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 1.6 1.3
Age < 15 1 9 8
Laboratories 2012
Smear (per 100 000 population) 0.4
Culture (per 5 million population) 17.0
Drug susceptibility testing (per 5 million population) 3.9
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 70   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 74  
Retreatment 63  
TB/HIV 2012 Number (%)
TB patients with known HIV status 56 (4)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.14 (0–0.79) 9.8 (2.7–23)
MDR-TB cases among notified pulmonary
TB cases
2 (0–9) 12 (3–28)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 724 (97%) 66 (55%) 790
Laboratory-confirmed MDR-TB cases 4 3 7
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data